137 related articles for article (PubMed ID: 10791249)
1. [The role of beta 2-adrenoceptor gene polymorphisms in asthma].
Sato R
Hokkaido Igaku Zasshi; 2000 Mar; 75(2):81-94. PubMed ID: 10791249
[TBL] [Abstract][Full Text] [Related]
2. Acute systemic effects of inhaled salbutamol in asthmatic subjects expressing common homozygous beta2-adrenoceptor haplotypes at positions 16 and 27.
Lee DK; Bates CE; Lipworth BJ
Br J Clin Pharmacol; 2004 Jan; 57(1):100-4. PubMed ID: 14678347
[TBL] [Abstract][Full Text] [Related]
3. Beta2-adrenergic receptor polymorphisms affect airway responsiveness to salbutamol in asthmatics.
Kotani Y; Nishimura Y; Maeda H; Yokoyama M
J Asthma; 1999 Oct; 36(7):583-90. PubMed ID: 10524541
[TBL] [Abstract][Full Text] [Related]
4. Proof-of-concept evaluation of trough airway hyper-responsiveness following regular racemic or levosalbutamol in genotype-stratified steroid-treated persistent asthmatic patients.
Anderson WJ; Short PM; Williamson PA; Morrison AE; Palmer C; Tavendale R; Lipworth BJ
Clin Sci (Lond); 2014 Jan; 126(1):75-83. PubMed ID: 23829494
[TBL] [Abstract][Full Text] [Related]
5. Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial.
Wechsler ME; Kunselman SJ; Chinchilli VM; Bleecker E; Boushey HA; Calhoun WJ; Ameredes BT; Castro M; Craig TJ; Denlinger L; Fahy JV; Jarjour N; Kazani S; Kim S; Kraft M; Lazarus SC; Lemanske RF; Markezich A; Martin RJ; Permaul P; Peters SP; Ramsdell J; Sorkness CA; Sutherland ER; Szefler SJ; Walter MJ; Wasserman SI; Israel E;
Lancet; 2009 Nov; 374(9703):1754-64. PubMed ID: 19932356
[TBL] [Abstract][Full Text] [Related]
6. Airway subsensitivity with long-acting beta 2-agonists. Is there cause for concern?
Lipworth BJ
Drug Saf; 1997 May; 16(5):295-308. PubMed ID: 9187530
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype.
Turki J; Pak J; Green SA; Martin RJ; Liggett SB
J Clin Invest; 1995 Apr; 95(4):1635-41. PubMed ID: 7706471
[TBL] [Abstract][Full Text] [Related]
8. Relationship between polymorphisms in the 5' leader cistron, positions 16 and 27 of the adrenergic β2 receptor gene and asthma in a Han population from southwest China.
Fu WP; Zhao ZH; Zhong L; Sun C; Fang LZ; Liu L; Zhang JQ; Wang L; Shu JK; Wang XM; Dai LM
Respirology; 2011 Nov; 16(8):1221-7. PubMed ID: 21801278
[TBL] [Abstract][Full Text] [Related]
9. Effect of ADRB2 (adrenergic receptor β2) gene polymorphisms on the occurrence of asthma and on the response to nebulized salbutamol in South Indian patients with bronchial asthma.
Shah NJ; Vinod Kumar S; Gurusamy U; Annan Sudarsan AK; Shewade DG
J Asthma; 2015 Oct; 52(8):755-62. PubMed ID: 25985706
[TBL] [Abstract][Full Text] [Related]
10. Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism.
Taylor DR; Drazen JM; Herbison GP; Yandava CN; Hancox RJ; Town GI
Thorax; 2000 Sep; 55(9):762-7. PubMed ID: 10950895
[TBL] [Abstract][Full Text] [Related]
11. Association between beta2-adrenergic receptor genetic polymorphisms and nocturnal asthmatic patients of Chinese Han nationality.
Yin K; Zhang X; Qiu Y
Respiration; 2006; 73(4):464-7. PubMed ID: 16369120
[TBL] [Abstract][Full Text] [Related]
12. Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.
Lima JJ; Thomason DB; Mohamed MH; Eberle LV; Self TH; Johnson JA
Clin Pharmacol Ther; 1999 May; 65(5):519-25. PubMed ID: 10340917
[TBL] [Abstract][Full Text] [Related]
13. Cross tolerance to salbutamol occurs independently of beta2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol.
Lee DK; Jackson CM; Bates CE; Lipworth BJ
Thorax; 2004 Aug; 59(8):662-7. PubMed ID: 15282385
[TBL] [Abstract][Full Text] [Related]
14. beta-2 Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians.
Gratze G; Fortin J; Labugger R; Binder A; Kotanko P; Timmermann B; Luft FC; Hoehe MR; Skrabal F
Hypertension; 1999 Jun; 33(6):1425-30. PubMed ID: 10373227
[TBL] [Abstract][Full Text] [Related]
15. Concomitant occasional use of salbutamol influences bronchoprotective responsiveness afforded by formoterol in patients with the glycine-16 genotype.
Sims EJ; Lipworth BJ
Eur J Clin Pharmacol; 2004 Jan; 59(11):791-5. PubMed ID: 14668964
[TBL] [Abstract][Full Text] [Related]
16. Beta(2)-adrenergic receptor polymorphisms and response to salbutamol among Indian asthmatics*.
Kukreti R; Bhatnagar P; B-Rao C; Gupta S; Madan B; Das C; Guleria R; Athavale AU; Brahmachari SK; Ghosh B
Pharmacogenomics; 2005 Jun; 6(4):399-410. PubMed ID: 16004558
[TBL] [Abstract][Full Text] [Related]
17. Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.
Bleecker ER; Postma DS; Lawrance RM; Meyers DA; Ambrose HJ; Goldman M
Lancet; 2007 Dec; 370(9605):2118-25. PubMed ID: 18156033
[TBL] [Abstract][Full Text] [Related]
18. Beta2-adrenergic receptor haplotype and bronchodilator response to salbutamol in patients with acute exacerbations of COPD.
Mokry M; Joppa P; Slaba E; Zidzik J; Habalova V; Kluchova Z; Micietova L; Rozborilova E; Salagovic J; Tkacova R
Med Sci Monit; 2008 Aug; 14(8):CR392-8. PubMed ID: 18667995
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of the ADRB2 gene and response to inhaled beta- agonists in children with asthma: a meta-analysis.
Finkelstein Y; Bournissen FG; Hutson JR; Shannon M
J Asthma; 2009 Nov; 46(9):900-5. PubMed ID: 19905915
[TBL] [Abstract][Full Text] [Related]
20. The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol.
Lee DK; Currie GP; Hall IP; Lima JJ; Lipworth BJ
Br J Clin Pharmacol; 2004 Jan; 57(1):68-75. PubMed ID: 14678342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
